췌장 및 담관 결석 관리 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Pancreatic And Bile Duct Stone Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,922,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,109,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,772,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 췌장 및 담관 결석 관리 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 촉진요인, 동향, 기회 및 과제를 포함한 주요 시장 역학에 대한 철저한 평가를 통해 시장 구조에 대한 심층적인 인사이트를 제공합니다.

주요 인사이트

• 췌장 및 담관 결석 관리 시장 규모(2024E) : 13억 달러
• 시장 전망치(2033F) : 19억 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 4.7%

췌장 및 담관 결석 관리 시장 - 조사 범위

췌장 및 담관 결석 관리 시장에는 췌장 및 담관 결석의 진단, 관리 및 치료를 위한 다양한 의료 시술 및 의료기기가 포함됩니다. 이 시장은 병원, 전문 클리닉, 수술 센터를 대상으로 하며, 내시경적 역행성 담관 췌담관 조영술(ERCP), 경피적 접근법, 첨단 수술 장비를 포함한 다양한 솔루션을 제공합니다. 시장 성장의 원동력은 췌장 및 담관 결석의 유병률 증가, 최소침습적 기술의 발전, 효과적인 관리 옵션에 대한 인식의 증가입니다.

시장 성장 촉진요인:

췌장 및 담관 결석 관리 시장의 성장을 촉진하는 몇 가지 요인이 있습니다. 고지방 식단과 비만과 같은 생활습관 요인으로 인한 췌장 및 담관 결석 발생률의 증가는 중요한 촉진요인입니다. 강화된 ERCP 기술, 혁신적인 결석 제거 장치 등 최소침습적 시술의 기술 발전이 성장에 기여하고 있습니다. 또한, 신흥국의 의료비 지출 증가와 의료 인프라 개선으로 고급 치료 옵션에 대한 접근성이 확대되고 있습니다.

시장 억제요인:

유망한 성장 전망에도 불구하고, 이 시장은 높은 시술 비용과 전문 지식의 필요성이라는 도전에 직면해 있습니다. 특히 의료 예산이 한정된 개발도상국에서는 고급 진단 및 치료 장비의 가격이 비싸다는 문제가 있습니다. 또한, 복잡한 시술로 인해 숙련된 전문가가 필요하며, 숙련된 인력이 부족한 지역에서는 시장 성장을 제한할 수 있습니다. 이러한 문제를 해결하기 위해서는 기술을 보다 저렴하게 제공하고, 의료 전문가에 대한 교육 및 훈련을 강화하는 노력이 필요합니다.

시장 기회:

췌장 및 담관 결석 관리 시장은 기술 혁신, 인구 동향, 진화하는 의료 제공 모델로 인해 큰 성장 기회를 맞이하고 있습니다. 첨단 영상 진단 시스템, 로봇 보조 수술과 같은 신기술의 개발은 치료 결과를 개선하고 회복 시간을 단축할 수 있습니다. 외래진료소, 재택의료 등 기존 환경 외에 이러한 기술의 적용이 확대되면서 시장 성장의 새로운 길이 열릴 것입니다. 이러한 기회를 활용하고 시장 진입을 강화하기 위해서는 전략적 파트너십, R&D 투자, 비용 효율적인 솔루션 도입이 필수적입니다.

본 보고서에서 다루는 주요 질문들

• 세계 췌장 및 담관 결석 관리 시장의 성장을 촉진하는 주요 요인은 무엇인가?
• 췌장 및 담관 결석 관리에서 어떤 기술 및 시술이 선호되고 있는가?
• 의료기술의 발전은 시장의 경쟁 구도를 어떻게 변화시키고 있는가?
• 시장에 기여하는 주요 플레이어는 누구이며, 시장 지위를 유지하기 위해 어떤 전략을 취하고 있는가?
• 세계 췌장 및 담관 결석 관리 시장의 새로운 트렌드와 향후 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 핵심성공요인

• 제품율/사용 상황 분석
• 외과수술 건수
• 신제품 발매와 승인
• 주요 규제 - 지역별
• PESTEL 분석
• Porters 분석
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 제품별
  • 적응증별
  • 최종사용자별
  • 지역별
• 2024년 시장 시나리오

제7장 세계 시장 수요(금액) 분석

• 시장 금액 분석, 2019-2023년
• 시장 금액 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대적 수익 기회

제8장 제품별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 금액 분석, 2019-2023년
• 시장 금액 예측, 2024-2033년
  • 전기 유압식/레이저 결석파쇄술
• 제품별 시장 매력 분석

제9장 적응증별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 금액 분석, 2019-2023년
• 시장 금액 예측, 2024-2033년
  • 췌장 결석
  • 담관 결석
• 적응증별 시장 매력 분석

제10장 최종사용자별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 금액 분석, 2019-2023년
• 시장 금액 예측, 2024-2033년
  • 병원
  • 외래 수술 센터
  • 전문 클리닉
• 최종사용자별 시장 매력 분석

제11장 지역별 : 세계 시장 분석

• 소개
• 시장 금액 분석, 2019-2023년
• 시장 금액 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 지역별 시장 매력 분석

제12장 북미 시장 분석

제13장 라틴아메리카 시장 분석

제14장 유럽 시장 분석

제15장 동아시아 시장 분석

제16장 남아시아 시장 분석

제17장 오세아니아 시장

제18장 중동 및 아프리카(MEA) 시장 분석

제19장 시장 구조 분석

• 기업 계층별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장 집중
• 시장 입지 분석

제20장 경쟁 분석

• 경쟁 대시보드
• 주요 기업에 의한 브랜딩과 프로모션 전략
• 주요 개발 분석
• 경쟁 상세
  • Boston Scientific Corporation
  • Argon Medical Devices
  • Olympus Endoscopy
  • Cook Medical
  • Medtronic Inc.
  • Conmed Endoscopic Technologies
  • CR BARD Inc(Becton, Dickinson and Company)
  • Cordis(Cardinal Health Inc.)
  • Zeon Medical Co., Ltd.
  • Medi-Globe(ENDO-Flex) GmbH
  • Taewoong Medical Co., Ltd.
  • Q3 Medical Devices

제21장 사용되는 가정과 두문자어

제22장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global pancreatic and bile duct stone management market. This report provides a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, and delivers detailed insights into the market structure.

Key Insights:

• Pancreatic and Bile Duct Stone Management Market Size (2024E): USD 1.3 Billion
• Projected Market Value (2033F): USD 1.9 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 4.7%

Pancreatic and Bile Duct Stone Management Market - Report Scope:

The pancreatic and bile duct stone management market involves a range of medical procedures and devices designed to diagnose, manage, and treat stones in the pancreatic and bile ducts. This market caters to hospitals, specialized clinics, and surgical centers, offering various solutions including endoscopic retrograde cholangiopancreatography (ERCP), percutaneous approaches, and advanced surgical instruments. The market growth is driven by increasing prevalence of pancreatic and bile duct stones, advancements in minimally invasive technologies, and rising awareness about effective management options.

Market Growth Drivers:

Several factors are propelling the growth of the pancreatic and bile duct stone management market. The increasing incidence of pancreatic and bile duct stones due to lifestyle factors, such as high-fat diets and obesity, is a significant driver. Technological advancements in minimally invasive procedures, such as enhanced ERCP techniques and innovative stone retrieval devices, contribute to the growth. Additionally, rising healthcare expenditure and improving healthcare infrastructure in emerging economies are expanding the accessibility of advanced treatment options.

Market Restraints:

Despite the promising growth prospects, the market faces challenges including high procedural costs and the need for specialized expertise. The cost of advanced diagnostic and treatment equipment can be prohibitive, especially in developing regions with limited healthcare budgets. Additionally, the complexity of the procedures requires skilled professionals, which may limit market growth in areas with a shortage of trained personnel. Addressing these challenges requires efforts to make technologies more affordable and increase training and education for healthcare professionals.

Market Opportunities:

The pancreatic and bile duct stone management market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of new technologies, such as advanced imaging systems and robotic-assisted surgery, offers improved treatment outcomes and reduced recovery times. Expanding applications of these technologies beyond traditional settings, such as in outpatient clinics and homecare, open new avenues for market growth. Strategic partnerships, investment in R&D, and the introduction of cost-effective solutions are essential to capitalize on these opportunities and enhance market reach.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the pancreatic and bile duct stone management market globally?
• Which technologies and procedures are gaining traction in the management of pancreatic and bile duct stones?
• How are advancements in medical technology reshaping the competitive landscape of the market?
• Who are the key players contributing to the market, and what strategies are they employing to maintain their market position?
• What are the emerging trends and future prospects in the global pancreatic and bile duct stone management market?

Competitive Intelligence and Business Strategy:

Leading players in the pancreatic and bile duct stone management market, including Medtronic plc, Boston Scientific Corporation, and Olympus Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced devices and procedures for effective stone management. Collaborations with healthcare providers, surgical centers, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research and evidence-based practices helps enhance patient outcomes and drive market growth.

Key Companies Profiled:

• Boston Scientific Corporation
• Argon Medical Devices
• Olympus Endoscopy
• Cook Medical
• Medtronic Inc.
• Conmed Endoscopic Technologies
• CR BARD Inc (Becton, Dickinson and Company)
• Cordis (Cardinal Health Inc.)
• Zeon Medical Co., Ltd.
• Medi-Globe (ENDO-Flex) GmbH
• Taewoong Medical Co., Ltd.
• Q3 Medical Devices

Key Segments Covered in Pancreatic and Bile Duct Stone Management Industry Research

Product:

• ERCP Catheters
• Guidewire
• Sphincterotome
• Dilation Balloon Catheters
• Extraction Balloon Catheters
• Extraction Basket Catheters
• Biliary Stents
• Self-Expandable Biliary Stents
• Dilation Large-Balloon Catheters
• Mechanical Lithotripsy
• Electrohydraulic/Laser Lithotripsy

Indication:

• Pancreatic Stones
• Bile Duct Stones

End User:

• Hospitals
• Ambulatory Surgical Centers
• Speciality Clinics

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Rate/Usage Analysis
• 4.2. Surgical Procedure Volume
• 4.3. New Product Launch & Approval
• 4.4. Key Regulations - By Region
• 4.5. PESTEL Analysis
• 4.6. Porter's Analysis
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Catheter, Stent and Guidewire Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Increasing Prevalence of Pancreatic Stones
  • 5.2.2. Rising Prevalence of Bile Duct Stones
  • 5.2.3. Technology Advancement
  • 5.2.4. Innovation and Development
  • 5.2.5. Regulatory Approvals
  • 5.2.6. Adoption Rate
  • 5.2.7. Number of Procedures Performed
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Indication
  • 6.1.3. By End User
  • 6.1.4. By Region
• 6.2. 2024 Market Scenario

7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2033
  • 8.3.1. Electrohydraulic/Laser Lithotripsy
• 8.4. Market Attractiveness Analysis, By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
  • 9.3.1. Pancreatic Stones
  • 9.3.2. Bile Duct Stones
• 9.4. Market Attractiveness Analysis, By Indication

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2033
  • 10.3.1. Hospitals
  • 10.3.2. Ambulatory Surgical Centers
  • 10.3.3. Speciality Clinics
• 10.4. Market Attractiveness Analysis, By End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
• 11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, By Region, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product
  • 12.3.3. By Indication
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By Indication
  • 12.4.4. By End User
• 12.5. Market Trends
• 12.6. Key Market Participants - Intensity Mapping
• 12.7. Drivers and Restraints - Impact Analysis
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. U.S. Market Analysis
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 12.8.1.2.1. By Product
      • 12.8.1.2.2. By Indication
      • 12.8.1.2.3. By End User
  • 12.8.2. Canada Market Analysis
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 12.8.2.2.1. By Product
      • 12.8.2.2.2. By Indication
      • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. Mexico
    • 13.3.1.2. Brazil
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Product
  • 13.3.3. By Indication
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Indication
  • 13.4.4. By End User
• 13.5. Market Trends
• 13.6. Key Market Participants - Intensity Mapping
• 13.7. Drivers and Restraints - Impact Analysis
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Mexico Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By Indication
      • 13.8.1.2.3. By End User
  • 13.8.2. Brazil Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By Indication
      • 13.8.2.2.3. By End User
  • 13.8.3. Argentina Market Analysis
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.8.3.2.1. By Product
      • 13.8.3.2.2. By Indication
      • 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. BENELUX
    • 14.3.1.7. Russia
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Product
  • 14.3.3. By Indication
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Indication
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Germany Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Indication
      • 14.8.1.2.3. By End User
  • 14.8.2. Italy Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Indication
      • 14.8.2.2.3. By End User
  • 14.8.3. France Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By Indication
      • 14.8.3.2.3. By End User
  • 14.8.4. U.K. Market Analysis
    • 14.8.4.1. Introduction
    • 14.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.4.2.1. By Product
      • 14.8.4.2.2. By Indication
      • 14.8.4.2.3. By End User
  • 14.8.5. Spain Market Analysis
    • 14.8.5.1. Introduction
    • 14.8.5.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.5.2.1. By Product
      • 14.8.5.2.2. By Indication
      • 14.8.5.2.3. By End User
  • 14.8.6. BENELUX Market Analysis
    • 14.8.6.1. Introduction
    • 14.8.6.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.6.2.1. By Product
      • 14.8.6.2.2. By Indication
      • 14.8.6.2.3. By End User
  • 14.8.7. Russia Market Analysis
    • 14.8.7.1. Introduction
    • 14.8.7.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.7.2.1. By Product
      • 14.8.7.2.2. By Indication
      • 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market End User (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. China
    • 15.3.1.2. Japan
    • 15.3.1.3. South Korea
  • 15.3.2. By Product
  • 15.3.3. By Indication
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Product
  • 15.4.2. By Indication
  • 15.4.3. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. China Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Indication
      • 15.8.1.2.3. By End User
  • 15.8.2. Japan Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Indication
      • 15.8.2.2.3. By End User
  • 15.8.3. South Korea Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Indication
      • 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Indonesia
    • 16.3.1.3. Malaysia
    • 16.3.1.4. Thailand
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product
  • 16.3.3. By Indication
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Indication
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. India Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Indication
      • 16.8.1.2.3. By End User
  • 16.8.2. Indonesia Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Indication
      • 16.8.2.2.3. By End User
  • 16.8.3. Malaysia Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Indication
      • 16.8.3.2.3. By End User
  • 16.8.4. Thailand Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Indication
      • 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Product
  • 17.3.3. By Indication
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Indication
  • 17.4.4. By End User
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. Australia Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Indication
      • 17.8.1.2.3. By End User
  • 17.8.2. New Zealand Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Indication
      • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkiye
    • 18.3.1.3. South Africa
    • 18.3.1.4. North Africa
    • 18.3.1.5. Rest of Middle East and Africa
  • 18.3.2. By Product
  • 18.3.3. By Indication
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Product
  • 18.4.2. By Indication
  • 18.4.3. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. GCC Countries Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Indication
      • 18.8.1.2.3. By End User
  • 18.8.2. Turkiye Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Indication
      • 18.8.2.2.3. By End User
  • 18.8.3. South Africa Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Indication
      • 18.8.3.2.3. By End User
  • 18.8.4. North Africa Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Indication
      • 18.8.4.2.3. By End User

19. Market Structure Analysis

• 19.1. Market Analysis, by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Concentration
• 19.4. Market Presence Analysis
  • 19.4.1. By Regional Footprints of Players
  • 19.4.2. By Product Footprints of Players
  • 19.4.3. By Channel Footprints of Players

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Branding and Promotional Strategies, By Key Players
• 20.3. Key Development Analysis
• 20.4. Competition Deep Dive
  • 20.4.1. Boston Scientific Corporation
    • 20.4.1.1. Overview
    • 20.4.1.2. Product Portfolio
    • 20.4.1.3. Sales Footprint
    • 20.4.1.4. Key Financials
    • 20.4.1.5. SWOT Analysis
    • 20.4.1.6. Strategy Overview
      • 20.4.1.6.1. Marketing Strategy
      • 20.4.1.6.2. Product Strategy
      • 20.4.1.6.3. Channel Strategy
  • 20.4.2. Argon Medical Devices
    • 20.4.2.1. Overview
    • 20.4.2.2. Product Portfolio
    • 20.4.2.3. Sales Footprint
    • 20.4.2.4. Key Financials
    • 20.4.2.5. SWOT Analysis
    • 20.4.2.6. Strategy Overview
      • 20.4.2.6.1. Marketing Strategy
      • 20.4.2.6.2. Product Strategy
      • 20.4.2.6.3. Channel Strategy
  • 20.4.3. Olympus Endoscopy
    • 20.4.3.1. Overview
    • 20.4.3.2. Product Portfolio
    • 20.4.3.3. Sales Footprint
    • 20.4.3.4. Key Financials
    • 20.4.3.5. SWOT Analysis
    • 20.4.3.6. Strategy Overview
      • 20.4.3.6.1. Marketing Strategy
      • 20.4.3.6.2. Product Strategy
      • 20.4.3.6.3. Channel Strategy
  • 20.4.4. Cook Medical
    • 20.4.4.1. Overview
    • 20.4.4.2. Product Portfolio
    • 20.4.4.3. Sales Footprint
    • 20.4.4.4. Key Financials
    • 20.4.4.5. SWOT Analysis
    • 20.4.4.6. Strategy Overview
      • 20.4.4.6.1. Marketing Strategy
      • 20.4.4.6.2. Product Strategy
      • 20.4.4.6.3. Channel Strategy
  • 20.4.5. Medtronic Inc.
    • 20.4.5.1. Overview
    • 20.4.5.2. Product Portfolio
    • 20.4.5.3. Sales Footprint
    • 20.4.5.4. Key Financials
    • 20.4.5.5. SWOT Analysis
    • 20.4.5.6. Strategy Overview
      • 20.4.5.6.1. Marketing Strategy
      • 20.4.5.6.2. Product Strategy
      • 20.4.5.6.3. Channel Strategy
  • 20.4.6. Conmed Endoscopic Technologies
    • 20.4.6.1. Overview
    • 20.4.6.2. Product Portfolio
    • 20.4.6.3. Sales Footprint
    • 20.4.6.4. Key Financials
    • 20.4.6.5. SWOT Analysis
    • 20.4.6.6. Strategy Overview
      • 20.4.6.6.1. Marketing Strategy
      • 20.4.6.6.2. Product Strategy
      • 20.4.6.6.3. Channel Strategy
  • 20.4.7. CR BARD Inc (Becton, Dickinson and Company)
    • 20.4.7.1. Overview
    • 20.4.7.2. Product Portfolio
    • 20.4.7.3. Sales Footprint
    • 20.4.7.4. Key Financials
    • 20.4.7.5. SWOT Analysis
    • 20.4.7.6. Strategy Overview
      • 20.4.7.6.1. Marketing Strategy
      • 20.4.7.6.2. Product Strategy
      • 20.4.7.6.3. Channel Strategy
  • 20.4.8. Cordis (Cardinal Health Inc.)
    • 20.4.8.1. Overview
    • 20.4.8.2. Product Portfolio
    • 20.4.8.3. Sales Footprint
    • 20.4.8.4. Key Financials
    • 20.4.8.5. SWOT Analysis
    • 20.4.8.6. Strategy Overview
      • 20.4.8.6.1. Marketing Strategy
      • 20.4.8.6.2. Product Strategy
      • 20.4.8.6.3. Channel Strategy
  • 20.4.9. Zeon Medical Co., Ltd.
    • 20.4.9.1. Overview
    • 20.4.9.2. Product Portfolio
    • 20.4.9.3. Sales Footprint
    • 20.4.9.4. Key Financials
    • 20.4.9.5. SWOT Analysis
    • 20.4.9.6. Strategy Overview
      • 20.4.9.6.1. Marketing Strategy
      • 20.4.9.6.2. Product Strategy
      • 20.4.9.6.3. Channel Strategy
  • 20.4.10. Medi-Globe (ENDO-Flex) GmbH
    • 20.4.10.1. Overview
    • 20.4.10.2. Product Portfolio
    • 20.4.10.3. Sales Footprint
    • 20.4.10.4. Key Financials
    • 20.4.10.5. SWOT Analysis
    • 20.4.10.6. Strategy Overview
      • 20.4.10.6.1. Marketing Strategy
      • 20.4.10.6.2. Product Strategy
      • 20.4.10.6.3. Channel Strategy
  • 20.4.11. Taewoong Medical Co., Ltd.
    • 20.4.11.1. Overview
    • 20.4.11.2. Product Portfolio
    • 20.4.11.3. Sales Footprint
    • 20.4.11.4. Key Financials
    • 20.4.11.5. SWOT Analysis
    • 20.4.11.6. Strategy Overview
      • 20.4.11.6.1. Marketing Strategy
      • 20.4.11.6.2. Product Strategy
      • 20.4.11.6.3. Channel Strategy
  • 20.4.12. Q3 Medical Devices
    • 20.4.12.1. Overview
    • 20.4.12.2. Product Portfolio
    • 20.4.12.3. Sales Footprint
    • 20.4.12.4. Key Financials
    • 20.4.12.5. SWOT Analysis
    • 20.4.12.6. Strategy Overview
      • 20.4.12.6.1. Marketing Strategy
      • 20.4.12.6.2. Product Strategy
      • 20.4.12.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

관련자료